Difficulty: Medium
Average Score: 69%
Practice
Which of the following is the first-line treatment for hypoxic-ischemic encephalopathy (HIE) in neonates?
Correct answer
A
Rationale
The correct answer is A) Therapeutic hypothermia as the first-line treatment for hypoxic-ischemic encephalopathy (HIE) in neonates. This intervention involves lowering the body temperature to reduce brain injury and improve neurological outcomes in newborns who have experienced perinatal asphyxia.
Surfactant therapy (B) is not the first-line treatment for HIE in neonates. Surfactant is primarily used to treat respiratory distress syndrome by improving lung function, not neurological conditions.
Ventilator support (C) is a supportive measure to assist breathing in neonates with respiratory issues but is not the first-line treatment for HIE. Diuretics (D) are used to manage specific conditions like edema or heart failure and are not indicated as the primary treatment for HIE.
Educationally, understanding the appropriate interventions for neonates with HIE is crucial for pediatric nurses and healthcare providers to optimize patient outcomes. Therapeutic hypothermia has been shown to be effective in reducing brain injury and improving long-term neurological outcomes, making it a critical component of care for neonates with HIE.
Surfactant therapy (B) is not the first-line treatment for HIE in neonates. Surfactant is primarily used to treat respiratory distress syndrome by improving lung function, not neurological conditions.
Ventilator support (C) is a supportive measure to assist breathing in neonates with respiratory issues but is not the first-line treatment for HIE. Diuretics (D) are used to manage specific conditions like edema or heart failure and are not indicated as the primary treatment for HIE.
Educationally, understanding the appropriate interventions for neonates with HIE is crucial for pediatric nurses and healthcare providers to optimize patient outcomes. Therapeutic hypothermia has been shown to be effective in reducing brain injury and improving long-term neurological outcomes, making it a critical component of care for neonates with HIE.